This inventor holds 1 USPTO granted patent. Top assignees: Biontech Rna Pharmaceuticals Gmbh, Tron—translationale Onkologie an Der Universitátsmedizin Der Johannes Gutenberg—universität Mainz Gemeinnützige Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 19 
1 out of 25 Years Active: 2026
Title: Bodo Tillmann: Inventor in RNA-Based Cancer Treatment.
Introduction
Bodo Tillmann is an inventor associated with Mainz, Germany. His work includes a patent concerning the use of cytokine-encoding RNA.
Latest Patents
Tillmann is listed as an inventor on 1 patent: “Treatment Using Cytokine Encoding RNA.” The patent focuses on an RNA-based approach involving cytokines.
Career Highlights
Tillmann has been associated with BioNTech RNA Pharmaceuticals GmbH and TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH. These organizations are connected with biotechnology and translational oncology research.
Collaborations
Tillmann’s listed coworker includes Ugur Sahin, a fellow figure associated with biotechnology and cancer research.
Conclusion
Bodo Tillmann’s recorded patent activity centers on cytokine-encoding RNA, reflecting his connection to research and development in biotechnology and oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile